Nordson Corporation · NDSN · FY2025 Q1 · Calendar Q1 2025
Nordson sees backlog strength despite softer sales
Nordson's near-term setup improved through stronger order entry, backlog growth, and acquisition integration, but the evidence is mixed because sales remained soft and full-year expectations were kept toward the lower end.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about NDSN FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management highlighted accelerating order entry and backlog growth, further Atrion integration, and new product activity. The company maintained guidance, while acknowledging that sales may land toward the low end.
Guidance delta
Full-year sales guidance was maintained, with management expecting results toward the lower end of the range.
Key takeaways
- Revenue was slightly below guidance, while margins remained robust.
- Order entry and backlog accelerated, improving second-half visibility.
- Atrion integration and new product launches remain central to the growth plan.
- Management maintained full-year guidance but expects sales toward the lower end.
Management priorities
- Continue integrating Atrion and roll out its Myocardial Protection System.
- Launch Orion Pro, the Harmony applicator, and additional optical sensors.
- Complete the industrial-coating manufacturing transition to South Carolina.
- Maintain R&D investment and disciplined capital spending.
Follow NDSN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| DA Davidson | Buy | Buy | Maintain | Aug 24, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 21, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 21, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 20, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | May 22, 2026 |
| Loop Capital | Buy | Hold | Upgrade | Jan 22, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Dec 17, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 23, 2024 |
| Jefferies | Hold | Buy | Downgrade | Sep 26, 2023 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 9, 2022 |
| B. Riley Securities | Buy | Buy | Maintain | May 23, 2018 |
| B. Riley FBR | Buy | Buy | Maintain | May 23, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Dec 15, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 23, 2016 |
| Wunderlich Securities | Buy | Hold | Upgrade | Jan 7, 2016 |
| Wunderlich | Buy | Hold | Upgrade | Jan 7, 2016 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Dec 14, 2015 |
| BB&T Capital | Buy | Hold | Upgrade | Oct 10, 2014 |
| Barrington Research | Outperform | Market Perform | Upgrade | Jun 18, 2014 |
| BMO Capital | Market Perform | Outperform | Downgrade | May 24, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $322.31. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Industrial Alliance Securities | Analyst unavailable | $375 | $332.21 | +16.3% | Aug 24, 2026 |
| Oppenheimer | Analyst unavailable | $370 | $335.74 | +14.8% | Aug 21, 2026 |
| Robert W. Baird | Michael Halloran | $351 | $334.7 | +8.9% | Aug 21, 2026 |
| KeyBanc | Analyst unavailable | $360 | $309.92 | +11.7% | Aug 20, 2026 |
| Oppenheimer | Analyst unavailable | $335 | $287.66 | +3.9% | May 29, 2026 |
| D.A. Davidson | Analyst unavailable | $345 | $287.91 | +7.0% | May 27, 2026 |
| Oppenheimer | Analyst unavailable | $325 | $292.66 | +0.8% | Feb 24, 2026 |
| Jefferies | Saree Boroditsky | $300 | $289.98 | -6.9% | Feb 23, 2026 |
| D.A. Davidson | Analyst unavailable | $335 | $290.13 | +3.9% | Feb 23, 2026 |
| Robert W. Baird | Analyst unavailable | $314 | $293.93 | -2.6% | Feb 20, 2026 |
| KeyBanc | Analyst unavailable | $325 | $299.29 | +0.8% | Feb 19, 2026 |
| Vertical Research | Analyst unavailable | $270 | $237.37 | -16.2% | Dec 15, 2025 |
| D.A. Davidson | Analyst unavailable | $290 | $235.21 | -10.0% | Dec 12, 2025 |
| Robert W. Baird | Analyst unavailable | $275 | $234.45 | -14.7% | Dec 12, 2025 |
| KeyBanc | Jeffrey Hammond | $295 | $236.19 | -8.5% | Dec 11, 2025 |
| D.A. Davidson | Matthew Summerville | $285 | $239.06 | -11.6% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $275 | $225.79 | -14.7% | Aug 25, 2025 |
| Robert W. Baird | Analyst unavailable | $252 | $227.17 | -21.8% | Aug 22, 2025 |
| Jefferies | Analyst unavailable | $240 | $219.93 | -25.5% | Aug 21, 2025 |
| KeyBanc | Analyst unavailable | $260 | $206.55 | -19.3% | Mar 4, 2025 |
| Robert W. Baird | Michael Halloran | $287 | $256.03 | -11.0% | Aug 23, 2024 |
| Loop Capital Markets | Chris Dankert | $255 | $246.44 | -20.9% | May 22, 2024 |
| Robert W. Baird | Michael Halloran | $272 | $245.85 | -15.6% | May 22, 2024 |
| D.A. Davidson | Matthew Summerville | $295 | $243.14 | -8.5% | May 21, 2024 |
| D.A. Davidson | Matt Summerville | $270 | $232.33 | -16.2% | Aug 21, 2023 |
| KeyBanc | Jeffrey Hammond | $255 | $221.04 | -20.9% | Feb 22, 2023 |
| Robert W. Baird | Analyst unavailable | $271 | $239.17 | -15.9% | Aug 24, 2022 |
| Morgan Stanley | Analyst unavailable | $250 | $218.04 | -22.4% | Jun 9, 2022 |
| Berenberg Bank | Andrew Buscaglia | $300 | $222.06 | -6.9% | Jun 7, 2022 |
Track every rating change on NDSN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment.…
Historical context
All NDSN earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | -2.0% | J.B. Hunt: Strong demand, but margin repair remains central |
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
- IBKRFY2026 Q3 · October 15, 2026+0.3% EPS-3.9% move
- AAFY2026 Q3 · October 15, 2026+20.5% EPS+7.2% move
- JBHTFY2026 Q3 · October 15, 2026+0.6% EPS-2.0% move
- PLDFY2026 Q3 · October 15, 2026+105.9% EPS-2.7% move
- BNYFY2026 Q3 · October 15, 2026+4.4% EPS+3.2% move
- USB-PRFY2026 Q3 · October 15, 2026+1.5% EPS— move
Get the NDSN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-02-05T00:02:40.001238+00:00
- Polygon adjusted daily market bars · 2026-10-17T03:40:39.904035+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T03:40:39.901277+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.